# Study of NI-071 in Comparison With Remicade in Patients With Rheumatoid Arthritis

> **NCT01567358** · PHASE1 · COMPLETED · sponsor: **Nichi-Iko Pharmaceutical Co., Ltd.** · enrollment: 14 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **BIOLOGICAL:** Infliximab
- **BIOLOGICAL:** Infliximab

## Key facts

- **NCT ID:** NCT01567358
- **Lead sponsor:** Nichi-Iko Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2012-12
- **Final completion:** 2013-04
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2013-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01567358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01567358, "Study of NI-071 in Comparison With Remicade in Patients With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01567358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*